Document is current

Article History

Received: 12 March 2020

Accepted: 15 July 2020

First Online: 28 July 2020

Ethics approval and consent to participate

: The Ohio University Institutional Review Board approved this study, and all study participants had to provide written informed consent in accordance with the Declaration of Helsinki for their participation. Furthermore, this study adheres to the CONSORT guidelines.

: Not Applicable.

: In the past 5-years, Brian Clark has received research funding from the NIH, Regeneron Pharmaceuticals, Astellas Pharma Global Development, Inc., RTI Health Solutions, Biophytis, and the Osteopathic Heritage Foundations. In the past 5-years, Brian Clark has received consulting fees from Regeneron Pharmaceuticals, Abbott Laboratories, and the Gerson Lehrman Group. Additionally, Brian Clark is co-founder with equity, and serves as the Chief of Aging Research, of AEIOU Scientific, LLC. In the past 5-years, Todd Manini has received research funding from the NIH, Regeneron Pharmaceuticals and Sanofi Pharmaceuticals for contracted studies that involved muscle related research. Todd Manini also owns publicly traded stock in Abbott Laboratories and Amgen Inc. who both make muscle health related products. Purchase of these stocks occurred prior to the beginning of the current research. In the past five years, David Russ has received research funding and consulting fees from Abbott Nutrition. All other authors declare no conflicts of interest, financial or otherwise.